Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine

In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provi...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Taweewun Hunsawong, Stefan Fernandez, Rome Buathong, Naretrit Khadthasrima, Kamonthip Rungrojchareonkit, Jindarat Lohachanakul, Rungarun Suthangkornkul, Kedsara Tayong, Angkana T. Huang, Chonticha Klungthong, Piyawan Chinnawirotpisan, Yongyuth Poolpanichupatam, Anthony R. Jones, Eric D. Lombardini, Supaporn Wacharapluesadee, Opass Putcharoen
Format:	article
Langue:	EN
Publié:	Centers for Disease Control and Prevention 2021
Sujets:	coronavirus disease COVID 19 inactivated SARS-CoV-2 vaccine neutralizing antibodies respiratory infections SARS-CoV-2 Medicine R Infectious and parasitic diseases RC109-216
Accès en ligne:	https://doaj.org/article/368ae157e44542878ce19741b4c002e4
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine

Documents similaires